| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000270223.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.009032464 |
Resistant |
| ENSG00000270223.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000944623 |
Resistant |
| ENSG00000270223.1 |
Gefitinib |
Skin cutaneous melanoma |
0.005163081 |
Resistant |
